AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 145 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,200 | +96.0% | 151,794 | +22.5% | 0.00% | +100.0% |
| Q1 2024 | $3,163 | +76.5% | 123,946 | -37.4% | 0.00% | 0.0% |
| Q4 2023 | $1,792 | +48.5% | 198,114 | +4.6% | 0.00% | 0.0% |
| Q3 2023 | $1,207 | -78.4% | 189,320 | -62.4% | 0.00% | -75.0% |
| Q2 2023 | $5,586 | -2.1% | 503,670 | +35.5% | 0.00% | +33.3% |
| Q1 2023 | $5,705 | -31.7% | 371,623 | -1.3% | 0.00% | -25.0% |
| Q4 2022 | $8,355 | -99.7% | 376,480 | +121.8% | 0.00% | +33.3% |
| Q3 2022 | $2,772,000 | +46.7% | 169,765 | +30.6% | 0.00% | +200.0% |
| Q2 2022 | $1,890,000 | +99.6% | 130,035 | +153.4% | 0.00% | 0.0% |
| Q1 2022 | $947,000 | – | 51,326 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 503,504 | $20,568,138 | 15.61% |
| Casdin Capital, LLC | 2,084,841 | $85,165,755 | 6.53% |
| COWEN AND COMPANY, LLC | 5,129,103 | $209,523,857 | 5.76% |
| RTW INVESTMENTS, LP | 8,806,838 | $359,759,332 | 5.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 517,734 | $21,149,434 | 4.99% |
| Propel Bio Management, LLC | 178,500 | $7,291,725 | 4.73% |
| Boxer Capital, LLC | 1,727,388 | $70,563,800 | 3.72% |
| Avoro Capital Advisors LLC | 6,505,000 | $265,729,250 | 3.54% |
| RA Capital Management | 5,400,408 | $220,606,667 | 2.92% |
| EAM Global Investors LLC | 116,615 | $4,763,723 | 1.07% |